Futura Medical (LON:FUM) Shares Down 9.8% – What’s Next?

Futura Medical plc (LON:FUM)’s stock price was down 9.8% during mid-day trading on Tuesday . The stock traded as low as GBX 0.32 and last traded at GBX 0.36. Approximately 695,996 shares were traded during mid-day trading, a decline of 93% from the average daily volume of 9,586,629 shares. The stock had previously closed at GBX 0.40.

Futura Medical Price Performance

The stock has a fifty day moving average of GBX 0.52 and a 200 day moving average of GBX 0.92. The stock has a market cap of £2.09 million, a price-to-earnings ratio of -0.13 and a beta of 0.02.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.